Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Sinovent

Biotech & Life Sciences · Suzhou Shi, China · Founded 2017 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value

Patent intelligence

$17M patent portfolio · 44 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$17M
1.3% of valuation · 212.4× the top peer Cerevel Therapeutics ($82k)
44 active patent families
Where Sinovent innovates Pharmaceutical SubstancesMedicinal chemistryPharmaceutical medicineCombinatorial chemistryPharmacology
Above peer median on Legal, Technology · Below peer median on Strategic, Market

Quality vs same-sector peers

Sinovent on the five Patsnap quality dimensions

Sinovent in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Sinovent concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Sinovent and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Sinovent on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.